Adeona Pharmaceuticals, a developer of medicines for serious central nervous system diseases, has appointed George J. Brewer, M.D., senior vice president of R&D. Dr. Brewer joins the Adeona management team after serving as chairman of the company's scientific advisory board for seven years.
Dr. Brewer is the Morton S. and Henrietta Sellner emeritus professor of human genetics and internal medicine at the University of Michigan. He was a member of the National Science Council's "Committee on Copper in Drinking Water" convened at the request of the Environmental Protection Agency in 2000 to consider the issue of what level of copper in drinking water could be considered "safe." Dr. Brewer has published over 500 scientific papers, several books and is the inventor of oral zinc therapy approved by the FDA in 1997, now standard of care for chronic Wilson's disease.